Caspase-6 inhibitors reverse the cognitive impairment caused by caspase-6 overexpression and loss of caspase-6 reduces other disease aspects in a mouse model of Huntington’s (Wong et al., 2015; Pakavathkumar et al., 2017). This evidence concerns the gene CASP6 and Cognitive impairment.